Level Bio AB (NGM:LEVBIO) Total Receivables: kr5.63 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NGM:LEVBIO Level Bio AB NGM:LEVBIO
22 GF Score
Price kr0.38
! 4 Warning Signs
View Full Analysis

What is Level Bio AB Total Receivables?

Level Bio AB NGM:LEVBIO +31.94% 22 Total Receivables is kr5.63 Mil as of Mar. 2026. GuruFocus rates NGM:LEVBIO with a GF Score™ of 22/100. The stock has 4 warning signs investors should review.

Level Bio AB's Total Receivables for the quarter that ended in Mar. 2026 was kr5.63 Mil.

Level Bio AB Total Receivables Historical Data

* Premium members only.

The historical data trend for Level Bio AB's Total Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Level Bio AB Total Receivables Chart

Level Bio AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.97 6.48 5.01 6.58 6.13

Level Bio AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.72 4.01 4.56 6.13 5.63
NGM:LEVBIO
22GF Score
Level Bio AB NGM:LEVBIO
Total Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Level Bio AB Total Receivables Calculation

Total Receivables is the sum of all receivables owed by customers and affiliates within one year, including:
Accounts Receivable
Notes Receivable
Loans Receivable
Other Current Receivables

Frequently Asked Questions Learn more about Total Receivables →
What does a Total Receivables of kr5.63 Mil mean?
Level Bio AB (NGM:LEVBIO) has a Total Receivables of kr5.63 Mil as of Mar. 2026. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on Level Bio AB and its competitors.
Is Level Bio AB's Total Receivables too high?
Level Bio AB's current Total Receivables is kr5.63 Mil. Overall, Level Bio AB has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does Level Bio AB's Total Receivables compare to TMO and DHR?
Level Bio AB's Total Receivables of kr5.63 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Receivables for a Medical Diagnostics & Research company?
A good Total Receivables depends on the Medical Diagnostics & Research industry context. However, Total Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Receivables mean?
A high Total Receivables can signal that a stock is expensive relative to its fundamentals. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on Level Bio AB and its competitors. Level Bio AB's current Total Receivables is kr5.63 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Level Bio AB stock overvalued right now?
Level Bio AB (NGM:LEVBIO) has a current Total Receivables of kr5.63 Mil. The current Total Receivables is kr5.63 Mil. Level Bio AB's overall GF Score™ is 22/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Receivables calculated?
Total Receivables is calculated from a company's financial statements. For Level Bio AB (NGM:LEVBIO), the current Total Receivables is kr5.63 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Level Bio AB Business Description

Address Vastra Finnbodavagen 4B, Nacka, Stockholm, SWE, 131 30
Level Bio AB is a parent company and operates through subsidiary. It develops and manufactures diagnostic kits for the clinical market and also is a distributor and full service partner to molecular biology labs in the Nordics.
22GF Score

Get the complete analysis for NGM:LEVBIO

Total Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr0.38
Price